Written by James Whitfield, CSCS, Exercise Physiologist & Performance Researcher
Medically reviewed by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Published:
All GLP-1 medications from licensed 503A compounding pharmacies Browse Products
Compare Hims vs Found for weight loss: pricing ($79 vs $149+), medications, coaching support, and doctor oversight. Find the right GLP-1 program for you.
Source Reviewed
Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team
This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides
Search and AI answer brief
Compare Hims vs Found for weight loss: pricing ($79 vs $149+), medications, coaching support, and doctor oversight. Find the right GLP-1 program for you.
Short answer
Compare Hims vs Found for weight loss: pricing ($79 vs $149+), medications, coaching support, and doctor oversight. Find the right GLP-1 program for you.
Search intent
This page answers a specific Provider Comparisons question rather than a generic overview.
What to verify
semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms
How to use it
Use this information to prepare sharper questions for a licensed provider.
Written by James Whitfield, CSCS, Exercise Physiologist & Performance Researcher
Medically reviewed by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Published:
Key Takeaway
Compare Hims vs Found for weight loss: pricing ($79 vs $149+), medications, coaching support, and doctor oversight. Find the right GLP-1 program for you.
Choosing between Hims and Found for weight loss treatment comes down to your priorities: Hims offers broader medication access with telehealth convenience, while Found provides more thorough coaching support alongside GLP-1 medications. Both platforms connect you with licensed physicians and deliver FDA-approved treatments, but they take distinctly different approaches to weight management support.
This comparison examines pricing, medication options, doctor oversight, and patient experience to help you determine which platform aligns with your weight loss goals. We'll analyze real costs, available treatments, and the level of ongoing support each service provides based on current offerings and verified patient experiences.
| Factor | Hims | Found |
| Starting Price | $79/month | $149/month |
| Primary Focus | Medication access | Coaching + medication |
| GLP-1 Options | Semaglutide, tirzepatide | Semaglutide, tirzepatide |
| Coaching Support | Basic app tracking | Dedicated health coach |
| Best For | Self-directed patients | thorough support seekers |
Hims positions itself as a simplified telehealth platform that removes barriers to weight loss medication access. The service connects patients with licensed physicians through a digital consultation process, focusing primarily on medication management rather than thorough lifestyle coaching.
The platform offers two main weight loss medication options: compounded semaglutide starting at $79 per month and compounded tirzepatide at $199 per month. These prices include the medication, physician consultation, and basic digital support tools through the Hims app. The consultation process takes approximately 15 minutes and can be completed entirely online without video calls.
Hims sources its GLP-1 medications from FDA-registered compounding pharmacies, which allows them to offer lower pricing compared to brand-name versions like Ozempic or Mounjaro. The compounded formulations are compounded preparations related to their brand-name counterparts but are prepared in specialized pharmacy facilities rather than manufactured by pharmaceutical companies.
Shipping typically takes 3-5 business days via temperature-controlled packaging to ensure medication stability. The platform includes injection supplies, alcohol swabs, and detailed administration instructions with each shipment. Patients receive their medication in pre-filled syringes or vials depending on their prescribed dosage.
The Hims app provides basic tracking features including weight logging, progress photos, and medication reminders. But the platform doesn't include dedicated health coaching, nutritional counseling, or behavioral support programs. Patient support is primarily handled through customer service representatives rather than licensed healthcare professionals.
Hims Pros:
Hims Cons:
Found takes a thorough approach to weight loss that combines GLP-1 medications with dedicated health coaching and behavioral support programs. The platform emphasizes long-term lifestyle changes alongside pharmaceutical intervention, positioning itself as a whole-body weight management solution. For a complete cost breakdown, see our cheapest GLP-1 without insurance.
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
Found's pricing structure is more complex than Hims, with plans starting at $149 per month for the coaching program plus separate medication costs that range from $99 to $349 monthly depending on the prescribed treatment. The total monthly cost typically ranges from $248 to $498, making it significantly more expensive than medication-only platforms.
The platform offers both brand-name and compounded versions of semaglutide and tirzepatide. Found works with patients' insurance when possible to reduce medication costs, though many GLP-1 treatments remain uncovered for weight loss indications. The clinical team includes board-certified physicians who specialize in obesity medicine and endocrinology.
Found's signature feature is its dedicated health coaching program. Each patient is assigned a certified health coach who provides weekly check-ins, personalized meal planning, exercise guidance, and behavioral support strategies. The coaching sessions are conducted via phone or video call and focus on sustainable habit formation rather than restrictive dieting approaches.
The Found app integrates with popular fitness trackers and provides thorough tracking for weight, measurements, food intake, physical activity, and medication adherence. The platform includes educational content, recipe databases, workout programs, and peer support communities to enhance the weight loss experience.
Medication delivery follows a similar timeline to other telehealth platforms, with 3-7 business days for initial shipments and automatic refills scheduled based on prescription requirements. Found provides injection training videos and offers live support calls for patients who need assistance with medication administration.
Found Pros:
Found Cons:
The cost difference between Hims and Found represents one of the most significant factors in choosing between these platforms. Hims focuses on affordable medication access, while Found's higher pricing reflects its thorough support model.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →For semaglutide treatment, Hims charges $79 per month total, including medication, consultation, and basic app access. Found's equivalent treatment costs $149 monthly for coaching plus $99-199 for medication, totaling $248-348 per month. This represents a 214-340% price difference for similar medication access.
Tirzepatide pricing shows an even larger gap. Hims offers compounded tirzepatide for $199 monthly, while Found's tirzepatide plans range from $149 coaching plus $297-349 medication, totaling $398-498 monthly. The annual cost difference can exceed $3,000 for tirzepatide treatment.
Found's higher pricing includes services that Hims doesn't provide: dedicated health coaching, thorough behavioral support, insurance coordination, and access to obesity medicine specialists. Patients must evaluate whether these additional services justify the substantial cost increase based on their individual needs and preferences.
Both platforms require upfront payment and don't accept insurance for their service fees, though Found assists with insurance claims for medication costs when coverage is available. Neither platform offers refunds for unused portions of monthly subscriptions, making the financial commitment more significant for Found users.
| Treatment | Hims Monthly Cost | Found Monthly Cost | Annual Difference |
| Semaglutide | $79 | $248-348 | $2,028-3,228 |
| Tirzepatide | $199 | $398-498 | $2,388-3,588 |
Both platforms provide access to the two most effective GLP-1 medications for weight loss: semaglutide and tirzepatide. But their sourcing strategies and medication quality approaches differ significantly, affecting both cost and potential efficacy.
Hims exclusively offers compounded versions of both medications through FDA-registered compounding pharmacies. Compounded semaglutide is prepared by licensed compounding pharmacies and is not FDA-approved as a finished drug product; formulation, pharmacy quality, dosing, and individual response can differ from brand-name semaglutide products. This approach allows Hims to offer lower pricing but may result in slight variations in potency or stability compared to FDA-approved brand-name versions.
Found provides both compounded and brand-name medication options depending on insurance coverage and patient preference. When insurance covers brand-name medications like Wegovy or Mounjaro, Found coordinates the prescription and prior authorization process. For patients without coverage, Found offers compounded alternatives at reduced costs.
The clinical effectiveness of compounded GLP-1 medications remains a topic of ongoing research. While compounding pharmacies must follow FDA guidelines for preparation and quality control, they aren't required to conduct the same extensive clinical trials as pharmaceutical manufacturers. Some patients report differences in side effect profiles or efficacy when switching between compounded and brand-name versions.
Both platforms follow similar dosing protocols, starting patients on low doses and gradually increasing based on tolerance and weight loss response. Hims physicians typically begin semaglutide at 0.25mg weekly and tirzepatide at 2.5mg weekly. Found's obesity medicine specialists may use more individualized dosing strategies based on patient medical history and weight loss goals.
Medication quality assurance varies between the platforms. Hims partners with a limited number of compounding pharmacies and provides basic quality certifications. Found conducts more extensive pharmacy vetting and offers transparency about medication sources, batch testing, and quality control measures.
The level of physician involvement and medical oversight represents a key difference between Hims and Found's approaches to weight loss treatment. Both platforms connect patients with licensed physicians, but the depth of medical supervision varies significantly.
Hims employs a network of licensed physicians who conduct initial consultations and provide ongoing prescription management. The consultation process is primarily text-based through the platform's messaging system, with physicians reviewing patient health questionnaires and medical history to determine treatment eligibility. Follow-up interactions are typically limited to prescription adjustments and basic safety monitoring.
Found's medical team includes board-certified physicians specializing in obesity medicine, endocrinology, and internal medicine. The platform emphasizes physician expertise in weight management and metabolic disorders, with doctors who have specific training in GLP-1 medication management and obesity treatment protocols.
The frequency of medical oversight differs substantially between platforms. Hims patients typically interact with physicians during initial consultation and when requesting prescription changes or reporting side effects. The platform relies on automated systems and customer service representatives for routine questions and basic support.
Found provides more intensive medical supervision with scheduled physician check-ins every 3-6 months and on-demand access for medical questions or concerns. The platform's physicians work closely with health coaches to monitor patient progress and adjust treatment plans based on weight loss response and side effect profiles.
Both platforms require patients to meet basic eligibility criteria for GLP-1 medications, including BMI requirements and absence of contraindicated medical conditions. But Found's physicians conduct more thorough medical evaluations, including review of laboratory results, cardiovascular risk factors, and potential drug interactions.
The quality of medical decision-making may be enhanced by Found's specialized physician network, though Hims' approach may be sufficient for patients with straightforward medical histories who prefer minimal medical oversight. Patients with complex medical conditions or multiple medications may benefit from Found's more intensive physician involvement.
Patient satisfaction data reveals distinct preferences between Hims and Found users, largely correlating with individual expectations and support needs. Both platforms maintain generally positive reviews, though specific satisfaction factors vary significantly.
Hims users frequently praise the platform's simplicity and affordability. Common positive feedback includes quick consultation processes, discreet delivery, and straightforward medication access without insurance complications. Patients who prefer self-directed weight loss approaches often appreciate Hims' minimal intervention model.
But Hims receives criticism for limited ongoing support and basic app functionality. Some users report feeling abandoned after initial prescription, particularly when experiencing side effects or weight loss plateaus. The lack of nutritional guidance and behavioral support frustrates patients seeking thorough weight management assistance.
Found's patient reviews consistently highlight the value of dedicated health coaching and thorough support systems. Users report higher satisfaction with long-term weight maintenance and lifestyle behavior changes. The platform's educational resources and community features receive particular praise from patients who benefit from structured guidance.
Found's main criticism centers on cost and complexity. Some patients find the higher pricing prohibitive for long-term use, while others report feeling overwhelmed by the platform's thorough approach. Patients preferring simple medication access sometimes view Found's coaching requirements as unnecessary intervention.
Weight loss outcomes appear comparable between platforms for medication effectiveness, though Found users may achieve better long-term maintenance due to behavioral support components. Clinical data is limited for direct platform comparisons, but individual medication efficacy should be similar given equivalent active ingredients.
Customer service quality differs notably between platforms. Hims primarily uses customer service representatives for support, which can result in delays for medical questions requiring physician input. Found's integration of clinical staff and health coaches provides more immediate access to qualified support for both medical and lifestyle concerns.
Choosing between Hims and Found depends primarily on your preferred level of support, budget constraints, and personal approach to weight management. Both platforms can be effective for appropriate patient populations, but they serve distinctly different needs and preferences.
Choose Hims if you: Prefer self-directed weight loss approaches, want the lowest possible medication costs, have straightforward medical history without complex conditions, are comfortable managing side effects independently, and value simplicity over thorough support systems.
Choose Found if you: Benefit from structured guidance and accountability, can afford higher monthly costs for thorough support, have struggled with weight maintenance in the past, prefer access to specialized obesity medicine physicians, and value behavioral coaching alongside medication treatment.
Patients with limited budgets or those who have successfully managed weight loss independently may find Hims' simplified approach sufficient for their needs. The platform works well for motivated individuals who primarily need medication access without extensive lifestyle intervention.
Found's thorough model suits patients who have experienced weight regain after previous diet attempts or those who struggle with emotional eating, portion control, or exercise consistency. The platform's higher cost may be justified for individuals who benefit significantly from professional coaching and behavioral support.
Consider FormBlends as an alternative that combines physician-supervised treatment with competitive pricing and personalized compounding options. Our clinical team provides individualized medication management with transparent pricing and direct physician access.
Neither platform accepts insurance for their service fees, but Found assists patients with insurance claims for brand-name medications when coverage is available. Hims focuses exclusively on cash-pay compounded medications. Most insurance plans don't cover GLP-1 medications for weight loss, though some may cover them for diabetes treatment.
Both platforms typically approve patients within 24-48 hours of completing their consultation. Hims' simplified process may result in slightly faster approval, while Found's more thorough evaluation may take an additional day. Medication shipping takes 3-7 business days for both platforms.
Hims provides customer service support and physician consultation for side effect management, though response times may vary. Found offers immediate access to health coaches and scheduled physician consultations for side effect evaluation and treatment adjustments. Both platforms can modify dosing or switch medications as needed.
Yes, patients can discontinue either service and switch to alternative providers. But neither platform offers refunds for unused portions of monthly subscriptions. You'll need a new consultation and prescription from your chosen platform, as prescriptions can't be transferred between telehealth services.
Compounded medications contain the specified active pharmaceutical ingredients. Compounded medications are not FDA-approved as finished products but are prepared in smaller batches by specialized pharmacies. While they should have similar clinical goals, some patients report differences in side effect profiles or effectiveness. Clinical research specifically comparing compounded versus brand-name GLP-1 medications is limited.
Both Hims and Found offer legitimate pathways to GLP-1 medication access, but your choice should align with your support needs, budget, and personal preferences for medical oversight. Consider your past experiences with weight loss attempts, current medical complexity, and long-term maintenance goals when evaluating these platforms.
If you're seeking a middle-ground approach that combines physician supervision with competitive pricing, consider exploring FormBlends' personalized weight loss programs. Our physician-supervised telehealth clinic offers individualized treatment plans with transparent pricing and direct access to medical professionals who specialize in metabolic health and weight management.
Take our free assessment to determine if GLP-1 medications are appropriate for your weight loss goals and discover personalized treatment options that fit your lifestyle and budget.
1. Hims & Hers Health, Inc. Weight Loss Treatment Options. Accessed March 2026. https://www.hims.com/weight-loss
2. Found Health Inc. Weight Loss Program Details. Accessed March 2026. https://www.found.health
3. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
5. FDA. Compounding and the FDA: Questions and Answers. Updated 2024. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
6. American Board of Obesity Medicine. Physician Certification Requirements. Accessed March 2026. https://www.abom.org
This article is for informational purposes only and doesn't constitute medical advice. GLP-1 medications may cause serious side effects and aren't appropriate for all patients. Consult with a qualified healthcare provider before starting any weight loss treatment. Individual results may vary, and no outcomes are guaranteed. Always follow your physician's guidance regarding medication use, dosing, and monitoring requirements.
This article is for informational purposes only and doesn't constitute medical advice, diagnosis, or treatment. The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician. Individual results vary. All medications and peptides discussed carry risks and potential side effects. Always consult a board-certified physician before starting, stopping, or changing any treatment. FormBlends provides physician-supervised telehealth services. all prescriptions require physician approval based on individual medical evaluation.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.
Evidence standard
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
FDA: unapproved GLP-1 drug safety concerns
RegulatorUsed for safety language around compounded, counterfeit, and unapproved GLP-1 products.
ADA Standards of Care in Diabetes 2026
GuidelineUsed for diabetes, cardiometabolic risk, and obesity-treatment context.
STEP 1 semaglutide obesity trial
TrialPrimary trial source for semaglutide 2.4 mg weight-loss expectations and side effects.
SURMOUNT-1 tirzepatide obesity trial
TrialPrimary trial source for tirzepatide weight-loss expectations and dose-response ranges.
PubMed evidence trail
For Hims vs Found Weight Loss: Medications, Coaching & Cost Compared, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition
Supports body-composition, lean-mass, and metabolic-risk context.
PubMed
Comparison decision path
Direct answer
Hims vs Found Weight Loss: Medications, Coaching & Cost Compared should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Compare Hims vs Found for weight loss: pricing ($79 vs $149+), medications, coaching support, and doctor oversight. Find the right GLP-1 program for you. Treat "Hims vs Found Weight Loss: Medications, Coaching & Cost Compared" as a way to pressure-test a decision before money, medication, or provider access is involved. The article ties cost and coverage, safety and pharmacy quality back to comparison and decision support. It belongs in a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm. Because this article has 10 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Keep the final call tied to your own labs, history, medications, and clinician guidance.
Original tools and data
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Editorial refresh
For this provider comparisons page, the 2026 refresh focuses on semaglutide, tirzepatide, cash-pay pricing, safety signals, hims, found so the article stays close to the question behind "Hims vs Found Weight Loss".
The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Hims vs Found Weight Loss from nearby GLP-1, peptide, hormone, or provider-comparison searches.
Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.
Custom 2026 image for Hims vs Found Weight Loss, provider comparisons, and better treatment decision-making.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.
Written by FormBlends Editorial Research
Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.
Ready to get started?
Provider-reviewed GLP-1 and peptide therapy, delivered to your door.
Start Your ConsultationGet a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.
Bariatric Surgery vs Glp-1 Cost Long Term. Compare costs, insurance coverage, and affordable alternatives for GLP-1 weight loss medications.
Provider ComparisonsBrand Mounjaro vs Compounded Tirzepatide Cost. Compare costs, insurance coverage, and affordable alternatives for GLP-1 weight loss medications.
Provider ComparisonsCompare brand Mounjaro vs compounded tirzepatide costs, quality, and effectiveness. Expert analysis of pricing, FDA approval, and patient outcomes to help...
Provider ComparisonsCompare brand name, compounded, and research peptides. Learn about quality differences, costs, safety risks, and which option provides the best value for...
Provider ComparisonsBrand Wegovy vs Compounded Semaglutide Cost. Compare costs, insurance coverage, and affordable alternatives for GLP-1 weight loss medications.
Provider ComparisonsThe price gap between brand-name and compounded GLP-1 medications is significant) often thousands of dollars per year. This compounded GLP-1 vs brand name cost resource covers the essential information you need to make informed decisions.
Provider-informed calculators to support your weight loss journey.
Check your body mass index and see if you may qualify for GLP-1 therapy.
Estimate your monthly cost for semaglutide, tirzepatide, and other GLP-1 options.
Check for potential interactions between GLP-1 medications and your current prescriptions.
Build a personalized titration schedule for your GLP-1 medication.